Pilar Martínez‐Sánchez

Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

Josep‐María Ribera, Mireia Morgades, Juana Ciudad et al. · Blood · 2020 · 84 citations · Full text

Medicine, Hematology, Oncology +12

Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries

Christian Récher, Christoph Röllig, Emilie Bérard et al. · Leukemia · 2021 · 66 citations · Full text

Medicine, Oncology, Pharmacology +12

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study

David Martínez‐Cuadrón, Juan Eduardo Megías‐Vericat, Josefina Serrano et al. · Blood Advances · 2021 · 65 citations · Full text

Medicine, Hematology, Oncology +17

Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular response

Pilar Martínez‐Sánchez, Laura Montejano, María Eugenia Sarasquete et al. · British Journal of Haematology · 2008 · 58 citations

Medicine, Hematology, Oncology +17

A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia

Esther Onecha, María Linares, Inmaculada Rapado et al. · Haematologica · 2018 · 51 citations · Full text

Medicine, Hematology, Oncology +17